Delaware | 76-0233274 | |
(State or other jurisdiction of | (IRS Employer | |
incorporation) | Identification No.) |
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Repros Therapeutics Inc. announced today that the Company's President and CEO, Joseph Podolski, will present a corporate overview on Monday, November 5, 2007, at 9:45 a.m. Eastern Time during the CIBC 19th Annual Healthcare Conference. Mr. Podolski will also present on Tuesday, November 6, 2007, at 12:20 p.m. Eastern Time during the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference.
A copy of the Company's press release is attached hereto as Exhibit 99.1. The press release is incorporated by reference herein a nd the foregoing description of the press release is qualified in its entirety by reference to the attached exhibit.
Repros Therapeutics Inc. | ||||||||
Date: October 29, 2007 | By: | /s/ Louis Ploth, Jr. | ||||||
Louis Ploth, Jr. | ||||||||
Vice President, Business Development and Chief Financial Officer | ||||||||
Exhibit No. | Description | |
EX-99.1 |